Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes

	Tweet

This study uses functional magnetic resonance imaging (fMRI) to learn how the brain functions in adolescents receiving fluoxetine (Prozac) cognitive behavioral therapy (CBT) or interpersonal therapy (IPT) for anxiety or depression in children/adolescents.

All participants will receive interviews to assess how they are doing in general, including general mood, degree of nervousness and behavior. Each participant and one of his or her parents will be interviewed separately and together. Those electing the medication study will also receive a physical examination. Participants are asked to complete tasks involving problem-solving and memory that involve looking at pictures, remembering things, testing reaction times, and making simple choices. 

Participants with anxiety or depression will first meet with a psychiatrist or psychologist for two weekly sessions of talk therapy. Those who remain anxious or depressed after these 2 weeks will have the 3 options based on their choice: 1) treatment with fluoxetine daily for 8 weeks 2) cognitive-behavioral therapy or interpersonal therapy (two kinds of talk therapy) once a week for 8 weeks 3) a random assignment (50% chance) to either placebo or fluoxetine for 8 weeks. During and after the 8 weeks of treatment, each participant will complete verbal and written symptom ratings. Blood samples will be drawn for laboratory tests before drug treatment and after it ends.

Those who have not improved by the end of the study will be offered other treatment for 1 to 3 months, and the clinicians will help with finding subsequent aftercare. Those who improve with treatment will continue therapy at NIH until an outside physician is able to assume responsibility for monitoring medication.

FOR MORE INFORMATION REGARDING THIS STUDY CALL THE CORE PHONE NUMBER: 301-496-5645

Sponsored by:  National Institute of Mental Health (NIMH)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00018057

RELATED STORIES:
Scientists Identify New Genetic Link to Autism   Army suicides set to hit new high in 2009   Facts About Childhood-Onset Bipolar Disorder   Brain chemical may play key role in anxiety   Survey shows how depression and smoking intertwine   Mother’s mental health tied to child’s development   Psychiatric problems another ephedra side effect   Mirror therapy may aid body image problems   Antidepressants no help for most people with bipolar disorder: study   Depression Increases Stroke Risk   New Treatment Approach May be Needed for Management of Depression in Some People with Bipolar Disord   Getting Serious About Suicide Prevention   Depression and Your Heart: Link between Depression, Coronary Heart Disease   DHEA may reduce depression symptoms in HIV patients   New data shows half of all children with autism wander and bolt from safe places

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]